<DOC>
	<DOCNO>NCT00512317</DOCNO>
	<brief_summary>To allow open-label extension patient complete Protocol 1042-0600 .</brief_summary>
	<brief_title>Open-label Extension Protocol 1042-0600</brief_title>
	<detailed_description>This open-label study evaluate efficacy safety ganaxolone treatment adult partial onset epilepsy without secondary generalization . The study consist 13 visit 108 ( +or-2 ) week .</detailed_description>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Epilepsies , Partial</mesh_term>
	<mesh_term>Pregnanolone</mesh_term>
	<criteria>1 . Subjects complete scheduled clinical study visit previous protocol 10420600 deem eligible ( major adverse event think drug relate ) Investigator . 2 . Diagnosis epilepsy CPS without secondarily generalize seizures accord International League Against Epilepsy [ ILAE ] Classification Epileptic Seizures ( 1981 ) . Diagnosis establish clinical history computerize tomography ( CT ) magnetic resonance imaging ( MRI ) brain rule progressive structural lesion electroencephalogram ( EEG ) video EEG result consistent partialonset epilepsy . 3 . Male female , 18 69 year age ( inclusive ) . [ Note : Subjects &gt; 69 year age good health condition may allow enter study discussion approval Medical Monitor . ] 4 . A 12lead electrocardiogram ( ECG ) without clinically significant abnormality . 5 . Be properly inform nature risk study give informed consent writing , prior enter study . 6 . Able participate full term study . 7 . Able keep seizure diary throughout course study . 8 . Sexually active woman childbearing potential must use medically acceptable method birth control negative qualitative serum betahuman chorionic growth hormone ( beta HCG ) pregnancy test result blood sample collect initial screen visit . A woman childbearing potential define female biologically capable become pregnant . A medically acceptable method birth control include intrauterine device place least 3 month , surgical sterilization , adequate barrier method ( e.g. , diaphragm foam ) . An oral contraceptive alone consider adequate purpose study . Use oral contraceptive combination another method ( e.g. , spermicidal cream ) acceptable . In subject sexually active , abstinence acceptable form birth control qualitative serum Î²HCG pregnancy test must test per protocol . 9 . Subjects history depression must stable may take one antidepressant medication Exclusion Criteria 1 . Presence nonmotor simple partial seizure . 2 . History pseudoseizures last 5 year . 3 . History primary generalize seizure last 5 year . 4 . Past use vigabatrin without stable visual field test twice 12 month last dose vigabatrin ( Concomitant use vigabatrin allow ) . 5 . Seizures secondary illicit drug alcohol use , infection , neoplasm , demyelinate disease , degenerative neurological disease , CNS disease deem progressive , metabolic illness , progressive degenerative disease . 6 . Status epilepticus within last year prior randomization in10420600 study . 7 . Clinically unstable psychiatric disorder within last 2 year . 8 . Suicide attempt within last 5 year current significant suicidal ideation . 9 . History psychosis within last 5 year . 10 . Current use neuroleptic psychosis . 11 . A significant medical surgical condition screen might compromise hematologic , cardiovascular , pulmonary , renal , gastrointestinal , hepatic system condition would place subject increase risk . 12 . Known sensitivity allergy progesterone relate steroid compound . 13 . History drug use alcohol abuse within past 5 year . 14 . Sexually active woman childbearing potential ( WCBP ) unwilling use doublebarrier method establish currently pregnant submit serum pregnancy test . 15 . A history chronic noncompliance drug regimen . 16 . Females currently breastfeed . 17 . Exposure investigational drug within 30 day prior randomization 10420600 study . 18 . Aspartate transaminase ( AST ) alanine transaminase ( ALT ) level &gt; 3 time upper limit normal ( ULN ) screening . 19 . Subject history repetitive seizure within 12month period precede study entry individual seizure count . 20 . Inability withhold grapefruit grapefruit juice diet entire clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>69 Years</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>partial onset epilepsy</keyword>
	<keyword>adult epilepsy</keyword>
	<keyword>partial seizure</keyword>
	<keyword>anticonvulsant</keyword>
	<keyword>catamenial epilepsy</keyword>
	<keyword>adult partial onset epilepsy</keyword>
</DOC>